Antonio Giordano
6PUBLICATIONS
62CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 09, 2026
VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer.Sara A Hurvitz, Rachel M Layman, Giuseppe Curigliano
|Apr 26, 2025
MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment.Ayako Nakashoji, Atrayee Bhattacharya, Hiroki Ozawa
|Apr 17, 2025
First-in-Human Phase I/IIa Study of the First-in-Class CDK2/4/6 Inhibitor PF-06873600 Alone or with Endocrine Therapy in Patients with Breast Cancer.Timothy A Yap, Jonathan W Goldman, Shaveta Vinayak
|Sep 03, 2024
A Phase II Study of Atezolizumab, Pertuzumab, and High-Dose Trastuzumab for Central Nervous System Metastases in Patients with HER2-Positive Breast Cancer.Antonio Giordano, Priya U Kumthekar, Qingchun Jin
|Jun 08, 2023
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer.Luca Licata, Giulia Viale, Mario Giuliano
|Nov 22, 2019
Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer.Antonio Giordano, Yueying Liu, Kent Armeson
Pageof 1
Frequent Collaborators
2 joint publications
Giuseppe Curigliano
1 joint publications
Luca Licata
1 joint publications
Lucia Del Mastro
1 joint publications
Fabio Puglisi
1 joint publications
Filippo Montemurro
1 joint publications
Claudio Vernieri
1 joint publications
Lajos Pusztai
1 joint publications
Giampaolo Bianchini
1 joint publications
Priya U Kumthekar
1 joint publications
Qingchun Jin
